@article {Podkaminer130, author = {Eugene Podkaminer}, title = {Smart Beta is the Gateway Drug to Risk Factor Investing}, volume = {43}, number = {5}, pages = {130--134}, year = {2017}, doi = {10.3905/jpm.2017.43.5.130}, publisher = {Institutional Investor Journals Umbrella}, abstract = {The most common strategies using risk factor approaches are found on the opposite ends of the complexity spectrum: simple, long-only equity factor strategies (i.e., smart beta) and multiasset class long/short risk premia approaches that often employ leverage and derivatives. The space between these two poles is just starting to be explored, as risk factors become a more common feature of both portfolio attribution and portfolio construction. Today{\textquoteright}s simple factor smart beta portfolios can be extended across multiple asset classes, coupled with shorting, in order to approach a diluted risk premia approach.TOPICS: Analysis of individual factors/risk premia, style investing, risk management}, issn = {0095-4918}, URL = {https://jpm.pm-research.com/content/43/5/130}, eprint = {https://jpm.pm-research.com/content/43/5/130.full.pdf}, journal = {The Journal of Portfolio Management} }